Print Email


To promote scientific exchange among health care professionals in oncology, cytotoxic therapy and its impact on the oral environment.

The Society provides a multidisciplinary forum for scientists and clinicians to focus on:

  • Concepts associated with oral consequences of antineoplastic therapy
  • Novel strategies germane to cancer research
  • Educational pursuits related to cancer and cancer therapy oral morbidity
  • Scientific diversity through collaboration

Learn More
The Genesis and Milestones of ISOO
ISOO ByLaws 

ISOO Membership Benefits:

  • ISOO membership connects you to an international group of professionals who share your interest in oral oncology. The annual MASCC/ISOO conferences have provided a basis for cooperation between members, cancer centers, countries and continents. 
  • Many collaborative projects have been launched through this meeting; most recently the Oral Care Study Group systematic reviews of oral side-effects of cancer therapy which have gone on to publication in the Journal of Supportive Care. 
  • ISOO members will have free access to the ISOO CE session held during the MASCC/ISOO Annual Symposium. 
  • ISOO members will continue to receive ISOO newsletters which (a) highlight upcoming meetings of interest (b) describe the ongoing work of MASCC and ISOO-led study groups and (c) connect ISOO members to each other in a fun and informal way, creating the ISOO family that we all enjoy.

Leadership - 2017-2019 Board of Directors

President: Allan Hovan, DMD, MSD, (FRCD) (Canada)
Immediate Past President and ISOO Representative: Ourania Nicolatou-Galitis, DDS, MSc, Dr Dent (Greece)
President Elect: Deborah P. Saunders, BSc, DMD (Canada)
Treasurer: Barbara Murphy, MD (USA)
Secretary: Siri Beier Jensen, DDS, PhD (Denmark)
Vice-President of Communications: Raj Nair, MSc, PhD, MRACDS (Australia)

Related Links:
Mouth Cancer Foundation
National Cancer Institute information on Oral Mucositis

ISOO Logo Toolkit